According to the U.S. Department of Health and Human Services Medicaid Provider Spending database, Medicaid payments tied to COVID-19–related HCPCS codes in Tallassee amounted to at least $8,344 in 2024.
Medicaid operates as a state-run public health insurance initiative funded in partnership by federal and state governments. It provides coverage to low-income individuals and families, children, seniors, and people with disabilities, making it a major segment of the U.S. health care landscape.
Since taxpayer funds support Medicaid payments, variations in local billing levels highlight shifts in community healthcare funding.
The analysis identified COVID-19–related services through HCPCS codes categorized as “COVID-19” or “coronavirus” in claims descriptions or supporting data. This means data only includes services explicitly classified as COVID-related in billing submissions and may not account for other pandemic-era care that used broader medical coding.
For context, in 2024 Birmingham posted the highest Medicaid COVID-19 service payments in Alabama, with $1,029,178 in related claims.
The city’s only Medicaid claims for COVID-19–related services in 2024 came from Community Hospital Inc.
Tallassee saw an increase in economic impact from COVID-19–specific Medicaid services during the pandemic years.
From 2021 to 2024, Medicaid payments over all other claim types climbed by $47,922, equal to a 7.7% rise.
According to the Centers for Medicare & Medicaid Services, overall state and federal Medicaid expenditures reached approximately $871.7 billion in fiscal year 2023, representing about 18% of all U.S. health spending. That compares to $613.5 billion in 2019, prior to the COVID-19 pandemic.
This jump is roughly 40% over several years, primarily driven by additional enrollees and expanded usage since the pandemic.
Federal budget legislation enacted by the Trump administration recently introduced proposals to trim the federal share of Medicaid and reorganize the program. The “One Big Beautiful Bill Act,” passed in 2025, is expected to reduce federal Medicaid spending by more than $1 trillion over the coming decade. Its provisions include work requirements and increased cost-sharing, which could limit coverage and funding options for some users, shifting more of the financial burden onto states as the program continues to assist millions of Americans.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $8,344 | -2.2% | $682,991 |
| 2023 | $8,528 | 162.3% | $914,765 |
| 2022 | $3,251 | -78.4% | $649,850 |
| 2021 | $15,073 | N/A | $641,797 |
| 2020 | $0 | N/A | $450,837 |
| 2019 | $0 | N/A | $565,084 |
| 2018 | $0 | N/A | $538,094 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $8,344 | 235 |
Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.
Details in this report come from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Find the source data here.

